Medicare AdvantageApril 8, 2024
Anthem expands specialty pharmacy precertification list
Effective for dates of service on and after August 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.
Federal and state law, as well as state contract language and CMS guidelines — including definitions and specific contract provisions/exclusions — take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
HCPCS or CPT® codes | Medicare Part B drugs |
J9286 | Columvi (glofitamab-gxbm) |
C9162, J3490, J3590, J9999 | Izervay (avacincaptad pegol) |
J9333 | Rystiggo (rozanolixizumab-noli) |
J9334 | Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc) |
We look forward to working together to achieve improved outcomes.
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-053057-24-CPN52693
PUBLICATIONS: May 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone